0

Lavanya Narra

KIMS Hospitals, India

Title: Colchicine in Cardiovascular diseases

Abstract

Colchicine has been used since ancient times mainly for gout and familial Mediterranean fever (FMF). The role of inflammation in the pathogenesis of atherosclerosis has paved the way for the use of anti-inflammatory drugs in the management of cardiovascular diseases (CVD). The role of colchicine as a standard of care for the management of pericarditis has been well established. Several clinical trials have highlighted the beneficial effects of colchicine in various CV conditions like coronary artery disease, atrial fibrillation, post-cardiac surgery and percutaneous coronary interventions. The widespread availability, low cost, and favorable side effect profile have made colchicine an attractive therapeutic option. Cardiologists need to be aware of the real-world clinical implications of using colchicine. 

Biography

Narra Lavanya has completed her DrNB Cardiology from Apollo Main Hospitals, Chennai. She is working as a Cardiologist at KIMS Hospital. She has over 30 publications in both national and international journals. She is currently pursuing her MSc in Heart failure from St George’s University of London.